Megan Clowse MD
Associate Professor, Medicine, Duke University School of Medicine
Join to view full profile
Duke Medical CtrDurham, NC 27710
Phone+1 919-620-4467
Dr. Clowse is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Johns Hopkins UniversityFellowship, Rheumatology, 2003 - 2005
MedStar Health Georgetown University (Baltimore)Residency, Internal Medicine, 1999 - 2002
Vanderbilt University School of MedicineClass of 1999
Certifications & Licensure
NC State Medical License 2005 - 2027
MD State Medical License 2003 - 2006
American Board of Internal Medicine Rheumatology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013-2014, 2016-2017
Clinical Trials
- Duke Lupus Registry
- Duke Autoimmunity in Pregnancy Registry
- Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE) Start of enrollment: 2013 Nov 20
Publications & Presentations
PubMed
- A quality improvement project to incorporate the mycophenolate Risk Evaluation and Mitigation Strategies in an academic lupus clinic.Dahima Cintron, Caitlan Pinotti, Jennifer L Rogers, Kai Sun, Rebecca Sadun
Lupus. 2026-08-01 - Enhancing Documentation of Contraception and Pregnancy Interest in the Rheumatology Clinic: A multi-site initiative.Megan E B Clowse, Puneet Bajaj, Bonnie Bermas, Julie Chiesa, Kathryn Dao
Arthritis Care & Research. 2026-07-13 - Differences in Self-Reported Medication Nonadherence and Its Drivers in Young Adults Versus Older Adults With Systemic Lupus Erythematosus.Hannah R Concannon, Kai Sun, Jennifer L Rogers, Megan E B Clowse, Rachel L Randell
The Journal of Rheumatology. 2026-07-01
Journal Articles
- Patient‐Reported Disease Activity and Adverse Pregnancy Outcomes in Systemic Lupus Erythematosus and Rheumatoid ArthritisNathaniel Harris, Megan Clowse, Arthritis Care & Research
Other
- General toxicity of cyclophosphamide and chlorambucil in inflammatory diseasesClowse MB, Stone JH
http://www.uptodate.com/contents/general-toxicity-of-cyclophosphamide-and-chlorambucil-in-inflammato
UpToDate, Wolters Kluwer Health - 2013-03-07
Authored Content
- Dapirolizumab Pegol Demonstrated Significant Improvement in Systemic Lupus Erythematosus Disease Activity: Efficacy and Safety Results of a Phase 3 TrialOctober 2024
- Reporting of Sex Effects by Systematic Reviews on Interventions for Depression, Diabetes, and Chronic PainApril 2016
- Reporting of Sex Effects by Systematic Reviews on Interventions for Depression, Diabetes, and Chronic PainApril 2016
Press Mentions
First-in-Class Lupus Drug Aces Phase III TestJune 12th, 2025- 3 AC&R Study Summaries: Maternal Health & SLE, Pregnancy Outcomes & Coordinated Ophthalmic & Rheumatologic CareFebruary 7th, 2025
- Dapirolizumab Pegol Reduces SLE Activity & Corticosteroid UseDecember 16th, 2024
Grant Support
- K24 Advancing Reproductive RheumatologyDUKE UNIVERSITY2024–2029
- The HOP-STEP Intervention: Improving Maternal Health in Women with Lupus through Improved Pregnancy Prevention and PlanningDUKE UNIVERSITY2022–2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
